Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bearish Engulfing | Bearish | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -4.47% | |
MACD Bullish Signal Line Cross | Bullish | -4.47% | |
Narrow Range Bar | Range Contraction | -4.47% | |
Doji - Bearish? | Reversal | -4.47% | |
Wide Bands | Range Expansion | -4.47% | |
Gapped Up | Strength | -4.47% | |
Doji - Bearish? | Reversal | -1.17% |
Alert | Time |
---|---|
Outside Day | about 13 hours ago |
Down 5% | about 13 hours ago |
Non-ADX 1,2,3,4 Bearish Retracement Entry | about 13 hours ago |
Fell Below Previous Day's Low | about 13 hours ago |
Down 3% | about 16 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2024
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants
Classification
Sector: Healthcare
Industry: Drug Manufacturers - General
Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.9799 |
52 Week Low | 0.76 |
Average Volume | 719,627 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 1.05 |
20-Day Moving Average | 0.93 |
10-Day Moving Average | 0.85 |
Average True Range | 0.09 |
RSI (14) | 39.76 |
ADX | 14.59 |
+DI | 17.13 |
-DI | 22.60 |
Chandelier Exit (Long, 3 ATRs) | 0.92 |
Chandelier Exit (Short, 3 ATRs) | 1.02 |
Upper Bollinger Bands | 1.12 |
Lower Bollinger Band | 0.74 |
Percent B (%b) | 0.31 |
BandWidth | 40.83 |
MACD Line | -0.07 |
MACD Signal Line | -0.07 |
MACD Histogram | 0.0026 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.96 | ||||
Resistance 3 (R3) | 0.97 | 0.94 | 0.94 | ||
Resistance 2 (R2) | 0.94 | 0.92 | 0.94 | 0.94 | |
Resistance 1 (R1) | 0.90 | 0.90 | 0.89 | 0.89 | 0.93 |
Pivot Point | 0.88 | 0.88 | 0.87 | 0.87 | 0.88 |
Support 1 (S1) | 0.83 | 0.85 | 0.82 | 0.83 | 0.79 |
Support 2 (S2) | 0.81 | 0.83 | 0.80 | 0.78 | |
Support 3 (S3) | 0.77 | 0.81 | 0.78 | ||
Support 4 (S4) | 0.76 |